Charlie Mills
born Charles N. Mills
Chairman of Medline Industries and its CEO from 1997 to 2023; son of co-founder Jim Mills and fourth-generation leader of the family's medical-supplies business · b. 1961 · Chicago, Illinois
Two calls made by hand, not formulas. how we score →
Summary
Charlie Mills's father co-founded Medline in 1966, and Charlie joined in 1986 as a sales rep after Cornell and a stint at IBM.
He became CEO in 1997 and ran the company for 26 years through its growth into the largest US medical-supplies maker and distributor. The founding was his father's. What he added was the long operating tenure and a family stake that survived a 2021 buyout and a 2025 IPO.
Where they worked
How it happened
Mills was born in 1961 in Chicago, the son of James "Jim" Mills, who co-founded Medline in 1966 with his brother Jon after leaving Cenco. Wikipedia's account of the company traces the family's medical-supply roots back further, to a great-grandfather's garment and hospital-supply businesses in the 1910s. Charlie is described as the fourth generation of family leadership. Sources consulted don't establish his household structure or his childhood in any detail.
He earned both a bachelor's degree in mechanical engineering and an MBA at Cornell University. Before joining the family company he worked as a sales representative at IBM. Who paid for his schooling isn't stated in the sources consulted.
Mills joined Medline in 1986 as a sales representative. Over the next decade he moved through sales management, vice president of marketing, and vice president of manufacturing, according to the company's investor-relations board biography. It was a broad rotation inside a business his father still ran.
He became chief executive in 1997, eleven years after joining. His cousin Andy Mills served as president. The company he took over already existed, already had national distribution, and was owned by his family. What separated him from other heirs is the 26 years he then spent running it as an operator while Medline became the largest privately held medical-supplies company in the US.
In June 2021 Blackstone, Carlyle and Hellman & Friedman bought Medline in a leveraged buyout that valued it at about $34 billion, one of the largest on record. Forbes reports the family sold 79% of the company in that deal, which means they kept a minority stake.
Mills stepped down as CEO in 2023, becoming chairman while Jim Boyle took over as chief executive in October. Medline listed on Nasdaq in December 2025 at $29 a share, raising more than $6.26 billion. Forbes says the extended Mills family, which includes four other billionaires, owns about 18% of the company after the offering.
Forbes lists his net worth at $11 billion as of October 11, 2026, ranking him 327th among the world's billionaires, with a self-made score of 4. Individual stakes within the family aren't disclosed, so the figure is a journalistic estimate of his share of a jointly held position in a now-public company.
The coded evidence
Thirteen groups, every claim sourcedHeadwinds coded 0. No identity-based resistance is documented. The ethnicity facet tag is omitted because sources consulted don't state it.
↗ en.wikipedia.orgFourth generation of a Chicago-area family business; no migration-linked factor is documented.
↗ en.wikipedia.orgnot established
Not established in sources consulted. Hardness is coded low from the family's ownership of an established company, not from a documented fallback.
↗ en.wikipedia.orgSalaried positions at IBM and then at the family company, starting in 1986. No self-funded venture or unpaid build period is documented.
↗ ir.medline.comThe hardship was imposed, not chosen. There was nothing to fall back on.
No period of chosen austerity is documented.
↗ en.wikipedia.orgFather James "Jim" Mills (1936-2019) co-founded Medline in 1966 and served as its long-time CEO. Mother's occupation is not established in sources consulted.
↗ en.wikipedia.orgA parent worked for themselves, the strongest known predictor of founding.
Father was a co-founder-owner of a privately held company.
↗ en.wikipedia.orgUncle Jon Mills co-founded the company with his father, and cousin Andy Mills was president during Charlie's tenure as CEO.
↗ forbes.comDescribed as the fourth generation of family leadership in medical supplies, going back to businesses founded in the 1910s.
↗ en.wikipedia.orgChicago, Illinois; the company's headquarters area is Northfield, Illinois.
↗ en.wikipedia.orgJoined his father's company in 1986 as a sales representative, which was a company his family owned and his father led.
↗ en.wikipedia.orgThe family company itself; he joined Medline in 1986 as a sales representative.
↗ en.wikipedia.orgMedline Industries, founded two decades before he joined, with existing manufacturing and distribution.
↗ en.wikipedia.orgCapital, Credibility, Network
↗ en.wikipedia.orgEleven years rotating through sales, sales management, marketing and manufacturing roles before becoming CEO.
↗ ir.medline.comNamed CEO in 1997 while his father's generation still owned and controlled the company.
↗ en.wikipedia.orgB.S. in mechanical engineering and an MBA, both from Cornell University.
↗ en.wikipedia.orgnot established
Not established. credentialFunding is coded family-funded as a placeholder judgment, not a sourced fact.
↗ en.wikipedia.orgA share of a family stake in Medline, owned jointly by the extended Mills family. Individual shares are not disclosed.
Forbes says the extended family owns about 18% after the December 2025 IPO.
↗ forbes.comFamily-owned until June 2021, when Blackstone, Carlyle and Hellman & Friedman bought the company in a leveraged buyout valuing it at about $34 billion. Forbes says the family sold 79% in that deal. Medline listed on Nasdaq in December 2025.
Forbes gives a different IPO-day valuation (above $55 billion) than Wikipedia ($37 billion); the figures likely measure different things and aren't reconciled here.
↗ en.wikipedia.orgRan the company as CEO for 26 years while the family held a controlling stake. Since 2021 the family has held a minority, and the company is now run by non-family executives, per Forbes.
↗ forbes.comNeither built nor bought; he took over operating leadership of a family company that already existed, then oversaw its growth.
↗ en.wikipedia.orgMedical supplies manufacturing and distribution
↗ forbes.com11000000000
Forbes real-time figure as of 2026-10-11. Forbes' 2026 Forbes 400 newcomers article (read via the Wayback Machine) also lists him at $11 billion, age 65, and calls him chairman of Medline. Wikipedia cites an earlier estimate of $10.9 billion.
↗ forbes.comJournalistic estimate
Medline is now publicly traded but the family's individual stakes are not separately disclosed, so Forbes' figure rests on an estimate of his share.
↗ forbes.com2026
↗ forbes.comnot established
Not established; a pre-IPO private company filed no proxy statement, and post-IPO filings were not checked.
↗ forbes.comMuch of the family's wealth was realized in part through the 2021 sale of 79% of the company; the retained stake is now in publicly traded shares, though the size of his personal holding isn't disclosed.
↗ forbes.comMedline's supply response to Hurricane Katrina (recognized by the American Red Cross), Hurricane Harvey and COVID-19, per Wikipedia.
↗ en.wikipedia.orgUncapped
↗ forbes.comnot established
None naming him personally found in sources consulted. Company-wide matters were not researched.
↗ en.wikipedia.orgLow profile, Long tenured
Inferred from sparse press coverage and his 26-year tenure, not from an explicit characterization.
↗ forbes.comPress
↗ forbes.comStructural context
The cost-of-failure score comes from this person's own money and circumstances. But who they were in America carried its own weight, the same way their household or income did, and it shaped how hard the path was just as much. That part isn't in the cost-of-failure number. It's here instead.
Men held about 90% of Fortune 500 CEO seats in 2023, and a wider majority of the rungs below. The ladder is widest for them the whole way up.
↗ forbes.comAmong the people recorded here — men: 225. Representation here is who reached these outcomes, not equal odds of reaching them.
Controlled comparisons
Each holds one thing constant and varies another, so the difference is the point. A list of similar names wouldn't tell you anything.